These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 12693313)

  • 21. [Is microalbuminuria, an early marker of clinical nephropathy, also a cardiovascular risk factor?].
    Raynaud E; Brun JF; Fédou C; Puech-Cathala AM; Pérez-Martin A; Orsetti A
    Ann Biol Clin (Paris); 1998; 56(6):671-9. PubMed ID: 9853026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intensified multifactorial intervention and cardiovascular outcome in type 2 diabetes: the Steno-2 study.
    Pedersen O; Gaede P
    Metabolism; 2003 Aug; 52(8 Suppl 1):19-23. PubMed ID: 12939735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of lisinopril on progression of retinopathy and microalbuminuria in normotensive subjects with insulin-dependent diabetes mellitus].
    Sjølie AK; Chaturvedi N; Fuller J
    Ugeskr Laeger; 1999 Feb; 161(7):949-52. PubMed ID: 10051804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiology patient pages. Cardiovascular disease in the diabetic patient.
    Goldfine AB; Goldfine HL
    Circulation; 2003 Jan; 107(2):e14-6. PubMed ID: 12538441
    [No Abstract]   [Full Text] [Related]  

  • 25. [Antihypertensive treatment in type II diabetes and diabetic nephropathy].
    Chantrel F; Bouiller M; Kolb I; Hannedouche T
    Nephrologie; 2000; 21(2):47-55. PubMed ID: 10798204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Should patients with type 2 diabetes focus on glycemic control to reduce their cardiovascular risk?
    Montori VM
    Pol Arch Med Wewn; 2008 Sep; 118(9):502-7. PubMed ID: 18846985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intensive diabetes management for high-risk patients: how best to deliver?
    Marshall SM
    Diabetes Care; 2009 Jun; 32(6):1132-3. PubMed ID: 19460918
    [No Abstract]   [Full Text] [Related]  

  • 28. Microalbuminuria: a common, independent cardiovascular risk factor, especially but not exclusively in type 2 diabetes.
    Donnelly R; Yeung JM; Manning G
    J Hypertens Suppl; 2003 Mar; 21(1):S7-12. PubMed ID: 12769161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reviewing statin therapy in diabetes--towards the best practise.
    Matikainen N; Kahri J; Taskinen MR
    Prim Care Diabetes; 2010 Apr; 4(1):9-15. PubMed ID: 20171948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical review 51: Implications of the Diabetes Control and Complications Trial.
    Eastman RC; Siebert CW; Harris M; Gorden P
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1105-7. PubMed ID: 8077299
    [No Abstract]   [Full Text] [Related]  

  • 31. Fibrates and microvascular complications in diabetes--insight from the FIELD study.
    Ansquer JC; Foucher C; Aubonnet P; Le Malicot K
    Curr Pharm Des; 2009; 15(5):537-52. PubMed ID: 19199980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of intensive blood pressure control with valsartan on urinary albumin excretion in normotensive patients with type 2 diabetes.
    Estacio RO; Coll JR; Tran ZV; Schrier RW
    Am J Hypertens; 2006 Dec; 19(12):1241-8. PubMed ID: 17161769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Risk and prevention of diabetic nephropathy].
    Ravera M; Re M; Deferrari G
    G Ital Nefrol; 2007; 24 Suppl 38():13-9. PubMed ID: 17922442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy.
    de Zeeuw D; Remuzzi G; Parving HH; Keane WF; Zhang Z; Shahinfar S; Snapinn S; Cooper ME; Mitch WE; Brenner BM
    Circulation; 2004 Aug; 110(8):921-7. PubMed ID: 15302780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in the diabetic retinopathy epidemiology after 14 years in a population of Type 1 and 2 diabetic patients after the new diabetes mellitus diagnosis criteria and a more strict control of the patients.
    Romero-Aroca P; Fernández-Balart J; Baget-Bernaldiz M; Martinez-Salcedo I; Méndez-Marín I; Salvat-Serra M; Buil-Calvo JA
    J Diabetes Complications; 2009; 23(4):229-38. PubMed ID: 18439844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Late complications of diabetes mellitus: risk factors in patients on sulfonylureas for more than 10 years.
    Hoshi M; Fujita S
    Jpn J Med; 1991; 30(6):616-7. PubMed ID: 1798228
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus.
    Reichard P; Nilsson BY; Rosenqvist U
    N Engl J Med; 1993 Jul; 329(5):304-9. PubMed ID: 8147960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of pregnancy on the natural history of diabetic retinopathy and nephropathy.
    Star J; Carpenter MW
    Clin Perinatol; 1998 Dec; 25(4):887-916. PubMed ID: 9891621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of Microvascular Complications of Diabetes.
    Crasto W; Patel V; Davies MJ; Khunti K
    Endocrinol Metab Clin North Am; 2021 Sep; 50(3):431-455. PubMed ID: 34399955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Should normotensive diabetic patients with microalbuminuria be treated with angiotensin converting enzyme inhibitors?].
    Feldt-Rasmussen BF
    Ugeskr Laeger; 2002 Apr; 164(14):1907-9. PubMed ID: 11957423
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.